Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Cash & Equivalents (2019 - 2026)

Analysis

Starling Oncology (STLN) Cash & Equivalents (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 1.01 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn 2.17 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn 107.70 Mn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 668.96 Mn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 138.80 Mn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 262.30 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 40.22 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn 164.45 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 158.04 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn 41.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.09 Mn
Mar 31, 2026 30.28 Mn
Dec 31, 2025 33.57 Mn
Sep 30, 2025 27.66 Mn
Jun 30, 2025 30.29 Mn
Mar 31, 2025 39.74 Mn
Dec 31, 2024 49.67 Mn
Sep 30, 2024 47.40 Mn
Jun 30, 2024 36.42 Mn
Mar 31, 2024 36.06 Mn
Dec 31, 2023 33.49 Mn
Sep 30, 2023 27.54 Mn
Jun 30, 2023 28.89 Mn
Mar 31, 2023 15.25 Mn
Dec 31, 2022 14.01 Mn
Sep 30, 2022 61.43 Mn
Jun 30, 2022 64.21 Mn
Mar 31, 2022 95.53 Mn
Dec 31, 2021 115.17 Mn
Sep 30, 2021 11.53 Mn